AndreaVenturaLab
@andreaventura.bsky.social
My lab at MSKCC studies the biology and genetics of cancer using a combination of genome editing, biochemical, and computational methods. Opinions are my own (Andrea)
https://venturalaboratory.com/
https://www.mskcc.org/research/ski/labs/andrea-ventura
https://venturalaboratory.com/
https://www.mskcc.org/research/ski/labs/andrea-ventura
“Now this is not the end. It is not even the beginning of the end. But it is, perhaps, the end of the beginning.” Winston Curchill
November 5, 2025 at 1:37 PM
“Now this is not the end. It is not even the beginning of the end. But it is, perhaps, the end of the beginning.” Winston Curchill
Reposted by AndreaVenturaLab
If you’re applying to your dream lab for an internship/PhD/postdoc, always send a second email 1-2 weeks after the first one if you don’t hear back.
I promise we will be grateful rather than annoyed. My email inbox is a disaster and I’m quite junior - and very few of us have secretarial support
I promise we will be grateful rather than annoyed. My email inbox is a disaster and I’m quite junior - and very few of us have secretarial support
October 4, 2025 at 5:47 AM
If you’re applying to your dream lab for an internship/PhD/postdoc, always send a second email 1-2 weeks after the first one if you don’t hear back.
I promise we will be grateful rather than annoyed. My email inbox is a disaster and I’m quite junior - and very few of us have secretarial support
I promise we will be grateful rather than annoyed. My email inbox is a disaster and I’m quite junior - and very few of us have secretarial support
Just visited @ifomresearch.bsky.social in Milan. It was a true pleasure to see the direction this cancer research institute has taken. The energy and the enthusiasm of the faculties was contagious. Plus, Milan is a thriving city. European science at the best.
October 4, 2025 at 1:08 PM
Just visited @ifomresearch.bsky.social in Milan. It was a true pleasure to see the direction this cancer research institute has taken. The energy and the enthusiasm of the faculties was contagious. Plus, Milan is a thriving city. European science at the best.
Reposted by AndreaVenturaLab
🚨 Fully funded #PhD opportunities at Human Technopole in Milan!
🔬 Apply by 9 June to join top research groups in Comp Bio, Struct Bio, Genomics, Neurogenomics, Mol Cell Bio
🌍 Open to grads worldwide via SEMM 👉 humantechnopole.it/en/news/10-f...
🔬 Apply by 9 June to join top research groups in Comp Bio, Struct Bio, Genomics, Neurogenomics, Mol Cell Bio
🌍 Open to grads worldwide via SEMM 👉 humantechnopole.it/en/news/10-f...
April 22, 2025 at 12:59 PM
🚨 Fully funded #PhD opportunities at Human Technopole in Milan!
🔬 Apply by 9 June to join top research groups in Comp Bio, Struct Bio, Genomics, Neurogenomics, Mol Cell Bio
🌍 Open to grads worldwide via SEMM 👉 humantechnopole.it/en/news/10-f...
🔬 Apply by 9 June to join top research groups in Comp Bio, Struct Bio, Genomics, Neurogenomics, Mol Cell Bio
🌍 Open to grads worldwide via SEMM 👉 humantechnopole.it/en/news/10-f...
Reposted by AndreaVenturaLab
You may be fearing your 401k is no longer enough for you to retire. But with all the cuts to NIH and Medicare you also won't live as long. So the policies are integrated.
April 7, 2025 at 1:20 AM
You may be fearing your 401k is no longer enough for you to retire. But with all the cuts to NIH and Medicare you also won't live as long. So the policies are integrated.
Great opportunity!
We have two #postdoc positions open to join my team at @ebi.embl.org in beautiful Cambridge!
We are a mission-driven, highly collaborative and dynamic team located at the Wellcome Genome Campus, one of the most exciting hubs in the world focused on biomedical research 👇
We are a mission-driven, highly collaborative and dynamic team located at the Wellcome Genome Campus, one of the most exciting hubs in the world focused on biomedical research 👇
Postdoctoral Fellow
Your group The Cortes-Ciriano group studies the mutational processes and mechanisms of genome instability underpinning tumourigenesis, immune escape, and drug response through the analysis of high-thr...
embl.wd103.myworkdayjobs.com
April 4, 2025 at 1:01 PM
Great opportunity!
Reposted by AndreaVenturaLab
More than 1,900 scientists write letter in ‘SOS’ over Trump’s attacks on science
Members of the National Academies of Sciences, Engineering and Medicine warned Americans of ‘real danger in this moment’
www.theguardian.com/us-news/2025...
Members of the National Academies of Sciences, Engineering and Medicine warned Americans of ‘real danger in this moment’
www.theguardian.com/us-news/2025...
www.theguardian.com
April 1, 2025 at 12:37 AM
More than 1,900 scientists write letter in ‘SOS’ over Trump’s attacks on science
Members of the National Academies of Sciences, Engineering and Medicine warned Americans of ‘real danger in this moment’
www.theguardian.com/us-news/2025...
Members of the National Academies of Sciences, Engineering and Medicine warned Americans of ‘real danger in this moment’
www.theguardian.com/us-news/2025...
Reposted by AndreaVenturaLab
I'll be in Boston/NYC/UPenn for <72 hrs this week explaining why Weizmann is the best school there is. If you know anyone that it can be relevant for - please DM me for details.
March 30, 2025 at 3:01 PM
I'll be in Boston/NYC/UPenn for <72 hrs this week explaining why Weizmann is the best school there is. If you know anyone that it can be relevant for - please DM me for details.
Reposted by AndreaVenturaLab
very much worth reading -- the stakes for the health and safety of all Americans could not be greater
Resignation letter from FDA’s Peter Marks (he was director of its Center for Biological Evaluation and Research)
March 29, 2025 at 6:30 AM
very much worth reading -- the stakes for the health and safety of all Americans could not be greater
Reposted by AndreaVenturaLab
....and to be followed by broad investment in science as the columnist suggests.
www.theguardian.com/commentisfre...
www.theguardian.com/commentisfre...
A French university is offering ‘scientific asylum’ for US talent. The brain drain has started | Alexander Hurst
The Trump administration is cutting funding, while specifically targeting institutions like Columbia. No wonder academics want out, says Guardian Europe columnist Alexander Hurst
www.theguardian.com
March 24, 2025 at 12:25 PM
....and to be followed by broad investment in science as the columnist suggests.
www.theguardian.com/commentisfre...
www.theguardian.com/commentisfre...
Reposted by AndreaVenturaLab
⌛📝 One week left to apply to our latest call for faculty positions here at @molbiolau.bsky.social in Aarhus, Denmark 🇩🇰
Two (👀) positions are available w. open topic + rank (tenure-track assist or assoc professorship dep. on career stage).
mbg.au.dk/en/news-and-...
Two (👀) positions are available w. open topic + rank (tenure-track assist or assoc professorship dep. on career stage).
mbg.au.dk/en/news-and-...
mbg.au.dk
March 24, 2025 at 11:50 AM
⌛📝 One week left to apply to our latest call for faculty positions here at @molbiolau.bsky.social in Aarhus, Denmark 🇩🇰
Two (👀) positions are available w. open topic + rank (tenure-track assist or assoc professorship dep. on career stage).
mbg.au.dk/en/news-and-...
Two (👀) positions are available w. open topic + rank (tenure-track assist or assoc professorship dep. on career stage).
mbg.au.dk/en/news-and-...
Reposted by AndreaVenturaLab
Save the Date! Cancer Molecular Therapeutics Research Association Annual Meeting in Utah July 13-17. Please register today. Incredible line up of speakers: RT! @andreaventura.bsky.social @rjdlab.bsky.social #lcsm
March 10, 2025 at 6:44 PM
Save the Date! Cancer Molecular Therapeutics Research Association Annual Meeting in Utah July 13-17. Please register today. Incredible line up of speakers: RT! @andreaventura.bsky.social @rjdlab.bsky.social #lcsm
Reposted by AndreaVenturaLab
Very excited to share the stellar speaker line-up at our ecDNA conference this June in London! 👇
If you're interested in #ecDNA and want to hear or present groundbreaking research, register now. Abstract submission deadline is 14 March.
Learn more: www.cancergrandchallenges.org/ecDNA-2025
If you're interested in #ecDNA and want to hear or present groundbreaking research, register now. Abstract submission deadline is 14 March.
Learn more: www.cancergrandchallenges.org/ecDNA-2025
February 24, 2025 at 10:29 AM
Very excited to share the stellar speaker line-up at our ecDNA conference this June in London! 👇
If you're interested in #ecDNA and want to hear or present groundbreaking research, register now. Abstract submission deadline is 14 March.
Learn more: www.cancergrandchallenges.org/ecDNA-2025
If you're interested in #ecDNA and want to hear or present groundbreaking research, register now. Abstract submission deadline is 14 March.
Learn more: www.cancergrandchallenges.org/ecDNA-2025
If you want to learn single-cell analysis from scratch with an user friendly, hands on, approach I very strongly recommend the series of FREE workshops offered by the SAIL team at @mskcancercenter.bsky.social , lead by @ronanchaligne.bsky.social .
sail.mskcc.org/computationa...
sail.mskcc.org/computationa...
Single-cell Data Analysis Workshop – Single-cell Analytics Innovation LabChaligne Lab Website
sail.mskcc.org
February 19, 2025 at 4:10 PM
If you want to learn single-cell analysis from scratch with an user friendly, hands on, approach I very strongly recommend the series of FREE workshops offered by the SAIL team at @mskcancercenter.bsky.social , lead by @ronanchaligne.bsky.social .
sail.mskcc.org/computationa...
sail.mskcc.org/computationa...
🧪 fellow scientists, any advice on a good primer for scRNAseq analysis. Not just the coding part, but the math behind it as well.
January 27, 2025 at 11:30 AM
🧪 fellow scientists, any advice on a good primer for scRNAseq analysis. Not just the coding part, but the math behind it as well.
Reposted by AndreaVenturaLab
In www.biorxiv.org/content/10.1... we propose that #KRAS #dosage integrates signaling & transcription to regulate cell states, driving #heterogeneity, progression & #metastasis
Transcriptional Dosage of Oncogenic KRAS Drives Lung Adenocarcinoma Cell States, Progression and Metastasis
Cancer cells display distinct, recurrent phenotypic cell states. Metastatic spreading correlates with tumor cell state evolution. However, the molecular mechanisms underlying metastasis remain elusive...
www.biorxiv.org
December 31, 2024 at 1:12 PM
In www.biorxiv.org/content/10.1... we propose that #KRAS #dosage integrates signaling & transcription to regulate cell states, driving #heterogeneity, progression & #metastasis
I’m reaching out about a Memorial Sloan Kettering Cancer Center event I’m participating in —Cycle for Survival. Right now, Cycle for Survival has a special year-end match going on — every donation is being doubled!
Cycle for Survival: The Movement to Beat Rare Cancers
Support rare cancer research at Memorial Sloan Kettering Cancer Center.
mskcc.convio.net
December 30, 2024 at 4:24 PM
I’m reaching out about a Memorial Sloan Kettering Cancer Center event I’m participating in —Cycle for Survival. Right now, Cycle for Survival has a special year-end match going on — every donation is being doubled!
🧪1/ 🚨New paper on ecDNAs from our lab!
We reveal a strategy to engineer extrachromosomal DNA (ecDNA) amplifications in cells & mice. Let's dive in! Let’s dive in! 🧵👇
www.nature.com/articles/s41...
We reveal a strategy to engineer extrachromosomal DNA (ecDNA) amplifications in cells & mice. Let's dive in! Let’s dive in! 🧵👇
www.nature.com/articles/s41...
Engineered extrachromosomal oncogene amplifications promote tumorigenesis - Nature
Large extrachromosomal DNAs are engineered using a CRISPR- and Cre–loxP-based approach and shown to drive cancer in mouse models, with potential applications in determining the role of oncogene a...
www.nature.com
December 18, 2024 at 4:54 PM
🧪1/ 🚨New paper on ecDNAs from our lab!
We reveal a strategy to engineer extrachromosomal DNA (ecDNA) amplifications in cells & mice. Let's dive in! Let’s dive in! 🧵👇
www.nature.com/articles/s41...
We reveal a strategy to engineer extrachromosomal DNA (ecDNA) amplifications in cells & mice. Let's dive in! Let’s dive in! 🧵👇
www.nature.com/articles/s41...
Reposted by AndreaVenturaLab
Hello to my small Bsky community. We have postdoc positions open to study epigenetic mechanisms contributing to resistance to chemo+immuno in TNBC, and projects related to epigenetic determinants of neurodevelopmental disorders. Feel free to reach out to me here/via email. Please like and repost!
December 11, 2024 at 6:57 PM
Hello to my small Bsky community. We have postdoc positions open to study epigenetic mechanisms contributing to resistance to chemo+immuno in TNBC, and projects related to epigenetic determinants of neurodevelopmental disorders. Feel free to reach out to me here/via email. Please like and repost!
Really interesting paper on how aging limits lung cancer progression by the Tammela lab www.nature.com/articles/s41...
Ageing limits stemness and tumorigenesis by reprogramming iron homeostasis - Nature
Studies using mouse models of lung adenocarcinoma identify an association between age, iron homeostasis and tumour initiation potential that involves NUPR1 and lipocalin-2.
www.nature.com
December 6, 2024 at 1:28 PM
Really interesting paper on how aging limits lung cancer progression by the Tammela lab www.nature.com/articles/s41...
Reposted by AndreaVenturaLab
#NatureMedicine is recruiting! We are looking for an editor to champion the areas of #Metabolism, #Endocrinology and #WomensHealth. Located in NY or Shanghai. Apply by Dec 2nd! Reach out if you have questions. @natureportfolio.bsky.social springernature.wd3.myworkdayjobs.com/SpringerNatu...
Associate or Senior Editor, Nature Medicine (Metabolism, Endocrinology & Women’s Health)
Title: Associate or Senior Editor, Nature Medicine (Metabolism, Endocrinology & Women’s Health) Location(s): New York or Shanghai - Hybrid Working Application Deadline: December 1st 2024 About Spr...
springernature.wd3.myworkdayjobs.com
November 28, 2024 at 11:34 AM
#NatureMedicine is recruiting! We are looking for an editor to champion the areas of #Metabolism, #Endocrinology and #WomensHealth. Located in NY or Shanghai. Apply by Dec 2nd! Reach out if you have questions. @natureportfolio.bsky.social springernature.wd3.myworkdayjobs.com/SpringerNatu...
Reposted by AndreaVenturaLab
1/23 Big news for the #ObenaufLab! So excited to finally share our new study providing another puzzle piece, why immunotherapy fails in many tumors, now out in @Nature 🧵👇 www.nature.com/articles/s41...
November 27, 2024 at 5:58 PM
1/23 Big news for the #ObenaufLab! So excited to finally share our new study providing another puzzle piece, why immunotherapy fails in many tumors, now out in @Nature 🧵👇 www.nature.com/articles/s41...